Is In Veritas Medical Diagnostics, Inc. (IVMED) a Buy, Sell, or Hold?
OTC : IVMED
In Veritas Medical Diagnostics, Inc.
$0.0007 USD
$0 (0.0%)
- Volume
- 304
- Average Volume
- 5
- Market Capitalization
- $120
- P/E Ratio
- -0.54
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.30
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Company Overview
OTC
G. T. Cooper
Shell Companies
Financial Services
IVMED
7
GB
USD
Liquidity Metrics
-0.52
0.00
0.00
0.00
0.00
Sales & Valuation
-$
0.00
-0.01
0.00
-0.01
Profitability
-$0.0018
-$107.8K
0.00%
0.00%
1.86%
-96.30%
P/E Metrics
-0.54
-0.48
-0.48
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-205.26
2/9
-$7.37M
$169.93K
$8.17M
-$2.07M
Key Metrics (TTM)
$3.67M
0.00
-34.02
0.00
1.86%
3.23%
-254.89%
-663961.67%
0 days
Company Executives
| Name | Title |
|---|---|
| G. T. Cooper | Chairman, Chief Executive Officer & President |
| Robert Galvin | Head of Administration & Financial Controller |
| Martin E. Thorp | Chief Financial Officer, Principal Accounting Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About In Veritas Medical Diagnostics, Inc. (OTC:IVMED) Stock
In Veritas Medical Diagnostics, Inc. operates as a development-stage firm, dedicated to researching and developing medical devices designed for near-patient or point-of-care diagnostic applications. The company's flagship product is a prothrombin monitor, crucial for evaluating blood clotting in patients vulnerable to cardiovascular events and cerebrovascular accidents. Beyond this, In Veritas Medical Diagnostics is actively developing a suite of other innovative products. These include a consumer-oriented device to predict labor onset for maternity planning; a comprehensive biomarker monitor that measures key indicators for conditions such as heart attack, HIV, cholesterol levels, and cancer; a non-invasive, continuous blood glucose concentration measurement device; a digital scanning mac ... hine offering a non-invasive alternative to traditional 2D X-ray imaging; an osteoporosis detection and monitoring device providing instant bone mineral density readings for affected patients; and a portable digital strip reader for immunoassay applications. The company, incorporated in Inverness, United Kingdom, adopted its current name, In Veritas Medical Diagnostics, Inc., in 2005, evolving from its previous identity as In Vivo Medical Diagnostics, Inc.
Frequently Asked Questions
-
What is the current In Veritas Medical Diagnostics, Inc. (IVMED) stock price?
-
In Veritas Medical Diagnostics, Inc.(OTC:IVMED) stock price is $0.0007 in the last trading session. During the trading session, IVMED stock reached the peak price of $0.3 while $0.0007 was the lowest point it dropped to. The percentage change in IVMED stock occurred in the recent session was 0.0% while the dollar amount for the price change in IVMED stock was $0.
-
IVMED's industry and sector of operation?
-
The OTC listed IVMED is part of Shell Companies industry that operates in the broader Financial Services sector.
-
Who are the executives of IVMED?
-
G. T. Cooper | Chairman, Chief Executive Officer & President
Robert Galvin | Head of Administration & Financial Controller
Martin E. Thorp | Chief Financial Officer, Principal Accounting Officer & Director
|
| -
How many employees does IVMED have?
-
Number of IVMED employees currently stands at 7. IVMED operates from The Green House, Inverness, None IV2 3Bl, GB.
-
Link for IVMED official website?
-
Official Website of IVMED is: https://www.whitebeard.ai
-
How do I contact IVMED?
-
IVMED could be contacted at phone #44 14 6366 7347 and can also be accessed through its website. IVMED operates from The Green House, Inverness, None IV2 3Bl, GB.
-
How many shares of IVMED are traded daily?
-
The average number of IVMED shares traded daily for last 3 months was 5.
-
What is the market cap of IVMED currently?
-
The market value of IVMED currently stands at $120 with its latest stock price at $0.0007